Indian regulators have approved the use of the Russian Sputnik V COVID19 vaccine, the German media DW reported citing the Russian Direct Investment Fund RDIF.The body  which markets the vaccine abroad  said that the Drug Controller General of India DCGI had approved the use of Sputnik V.India, the worlds 2nd most populous nation, became the 60th country to register #SputnikV after positive results of local Phase 3 clinical study. Sputnik V is now authorized in 60 countries with a population of over 3 [billion] people, a tweet from Sputnik Vs official account read.Earlier on Monday, the Indian media had reported that the expert committee of Indias drug regulator had recommended granting an Emergency Use Authorization to Sputnik V.The Subject Expert Committee SEC of the Central Drugs Standard Control Organization CDSCO was deliberating on an application by pharmaceutical company Dr Reddys Laboratories, that had sought the authorization for Sputnik V.The recommendation comes as the South Asian nation battles an uptick in cases of the virus, amid reports of vaccine shortages and an overwhelmed health infrastructure in several states.On Monday, India overtook Brazil to become the second worsthit nation in the world, in overall terms, reporting a daily record of 168,912 new cases.The countrys total COVID19 caseload stood at 13.53 million  surpassing Brazils 13.45 million  according to data from Johns Hopkins University.India has administered some 105 million shots among a population of over 1.3 billion, so far.Sputnik V, if approved by the DCGI, will the third coronavirus vaccine authorized for use in the country, after the OxfordAstraZeneca vaccine, known in India as Covishield, and the indigenous Covaxin.